BNGO Insider Trading Activity and SEC Form 4 Filings
BNGO insider trading summary
Over the past 12 months, insiders at Bionano Genomics, Inc. (BNGO) reported 1 open-market purchase worth $5K by 1 insider and no sales on SEC Form 4. Net insider buying was $5K.
Latest BNGO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Albert Luderer | Interim Chief Executive | Buy | $5K (4,000 @ $1.22) |
| Jun 13, 2023 | Hannah Mamuszka | Director | Buy | $50K (65,789 @ $0.76) |
| May 16, 2023 | R. Erik Holmlin | President and CEO | Buy | $10K (15,000 @ $0.64) |
| May 12, 2023 | Christopher P. Stewart | Chief Financial Officer | Buy | $33K (50,000 @ $0.67) |
| Aug 15, 2022 | Yvonne Linney | Director | Sell | $72K (20,000 @ $3.62) |
| May 16, 2022 | David L Barker | Director | Buy | $16K (10,000 @ $1.60) |
| Nov 29, 2021 | R. Erik Holmlin | President and CEO | Buy | $597 (150 @ $3.98) |
| Nov 29, 2021 | R. Erik Holmlin | President and CEO | Buy | $11K (2,675 @ $3.99) |
| Nov 29, 2021 | R. Erik Holmlin | President and CEO | Buy | $9K (2,200 @ $3.98) |
| Aug 23, 2018 | Domain Partners VIII, L.P. | 10% Owner | Buy | $92K (15,000 @ $6.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.